 
        Professor  
        Kadir  
        Yeşilbağ  
        
        Professor  
        Kadir  
        Yeşilbağ  
        Head of Department  - Veterinary Virology  
        Bursa Uludag University  
LinkedIn 
View profileBiography
        Obtained academic degrees:
- Prof.	                     : 2010, Uludağ University Faculty of Veterinary Medicine, Bursa     
- Assoc Prof.	     : 2005, Uludağ University Faculty of Veterinary Medicine, Bursa     
-Assist. Prof	     : 2003, Uludağ University Faculty of Veterinary Medicine, Bursa     
- PhD	                     : 2000, Ankara University Faculty of Veterinary Medicine, Ankara     
-Graduation     .   : 1994, Ankara University Faculty of Veterinary Medicine, Ankara     
Business Experience:
- 2000-             Uludağ University Faculty of Veterinary Medicine, Department of     
                            Virology, Bursa-Turkey     
-1994-2000,    Ankara University Faculty of Veterinary Medicine, Department of 
                                Virology, Ankara-Turkey     	
Study Abroad:
-1999, Inst. for Animal Health, Pirbright Lab. London , UK. (6 weeks, Project studies)
- 2006, Justus-Liebig University Fac. Vet Med, Inst for Virology, Giessen-Germany (6 weeks, Project studies)
- 2009, Justus-Liebig University Fac. Vet Med, Inst for Virology, Giessen-Germany (3 months,DAAD research grant)
- 2010, Stara Zagora University Fac. Vet.Med, Bulgaria (ERASMUS)
- 2013, Justus-Liebig University Fac. Vet Med, Inst for Virology, Giessen-Germany (ERASMUS)
- 2017, Hannover University of Veterinary Medicine, Inst for Virology, Hannover-Germany (3 months, DAAD research grant)
International Courses :
-	1999, Laboratory diagnosis of rinderpest, peste des petits ruminants (PPR), bluetongue and the Pox diseases, Inst. for Animal Health, Pirbright Lab. Surrey-London, UK.
-	
Memberships :
-	ESVV (European Society for Veterinary Virology)
-	ASM (American Society for Microbiology)
-	Turkish Association for Veterinary Microbiologists 
-       Turkish Association for Biosafety and Biosecurity
  Research interests
        vaccine development, vaccinal strain characterization,  formulation, clinical efficiency and safety testing, field efficiency testing  Projects you're working on
        1. Development of Vaccine Against Bovine Viral Diarrhea Virus Using Local Strains. -PROJECT LEADER
2.Serological Characteristics of Bovine Viral Diarrhoea Virus (BVDV) Isolates from Türkiye and Determination of Immunity Levels of BVDV Vaccines Used in Turkey Against Local Strains --PROJECT LEADER
3.  Development of Combined Escherichia coli, Rotavirus and Coronavirus Vaccine for Cattle. -PROJECT LEADER
4. Enhancing the Immune Effect of Foot and Mouth Disease Vaccines with Oligonucleotides Containing CpG Motifs.- RESEARCHER
5.  Development of inactivated COVID-19 vaccine.- RESEARCHER
6. Development of pentavalent FMD vaccine. - SUPERVISER - PROJECT CONCEPTUALIZATION
7. Development and field trials of a vaccine against Lumpy skin disease (LSD) virus. - SUPERVISER - PROJECT CONCEPTUALIZATION
8.  Development of a rabies vaccine for use in animals.- SUPERVISER - PROJECT CONCEPTUALIZATION
9.  Development of Locally Produced Rabies Vaccine for Humans.- SUPERVISER - PROJECT CONCEPTUALIZATION
  Discipline
        Challenge model development      Challenge study design      Clinical trials – efficacy      Clinical trials – safety      Epidemiology      Immunology – B-cells      Immunology – T-cells      Immunology – innate      Registration      Safety evaluation      Virology  Host species
        Cats      Cattle      Dogs      Horses      Small ruminants      Zoonoses  Pathogen
        Viruses      Viruses›Bluetongue virus      Viruses›Bovine viral diarrhoea      Viruses›Capripoxvirus      Viruses›Coronavirus      Viruses›Foot-and-mouth disease virus      Viruses›Herpesvirus      Viruses›Infectious bursal disease virus      Viruses›Parainfluenza virus      Viruses›Paramyxoviruses      Viruses›Peste des petits ruminants virus      Viruses›Poxviruses      Viruses›Rabies virus      Viruses›Respiratory syncytial virus      Viruses›Rotavirus  Stage of vaccine development
        Adjuvants      Clinical trials      Field trials      Pre-clinical trials      Vaccine delivery